173 related articles for article (PubMed ID: 30505055)
1. Cutaneous adverse drug reactions with fixed-dose combinations: Special reference to self-medication and preventability.
Tripathy R; Pattnaik KP; Dehury S; Patro S; Mohanty P; Sahoo SS; Mohanty S
Indian J Pharmacol; 2018; 50(4):192-196. PubMed ID: 30505055
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India.
Mittal N; Gupta M; Singla M
Cutan Ocul Toxicol; 2014 Dec; 33(4):289-93. PubMed ID: 24517496
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous Adverse Drug Reactions in a Tertiary Care Teaching Hospital in India: An Intensive Monitoring Study.
Thakkar S; Patel TK; Vahora R; Bhabhor P; Patel R
Indian J Dermatol; 2017; 62(6):618-625. PubMed ID: 29263536
[TBL] [Abstract][Full Text] [Related]
4. Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: A multicenter, cross-sectional study in Lahore, Pakistan.
Iftikhar S; Sarwar MR; Saqib A; Sarfraz M
PLoS One; 2018; 13(6):e0199456. PubMed ID: 29949616
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous adverse drug reactions in Indian population: A systematic review.
Patel TK; Thakkar SH; Sharma D
Indian Dermatol Online J; 2014 Dec; 5(Suppl 2):S76-86. PubMed ID: 25593813
[TBL] [Abstract][Full Text] [Related]
6. Trends in culprit drugs and clinical entities in cutaneous adverse drug reactions: a retrospective study.
Wang F; Zhao YK; Li M; Zhu Z; Zhang X
Cutan Ocul Toxicol; 2017 Dec; 36(4):370-376. PubMed ID: 28423957
[TBL] [Abstract][Full Text] [Related]
7. Incidence of cutaneous adverse drug reactions among medical inpatients of Sultanah Aminah Hospital Johor Bahru.
Latha S; Choon SE
Med J Malaysia; 2017 Jun; 72(3):151-156. PubMed ID: 28733562
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous Adverse Drug Reactions (CADRs)-Statistical Analysis of the Causal Relationship between the Drug, Comorbidities, Cofactors, and the Cutaneous Reaction-A Single-Centered Study.
MachoĊ N; Lewandowska J; Zdanowska N; Placek W; Owczarczyk-Saczonek A
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805639
[TBL] [Abstract][Full Text] [Related]
9. Severe cutaneous adverse reactions due to inappropriate medication use.
Chaby G; Valeyrie-Allanore L; Duong TA; Lebrun-Vignes B; Milpied B; Sassolas B; Tetart F; Wolkenstein P; Chosidow O; Fardet L
Br J Dermatol; 2018 Aug; 179(2):329-336. PubMed ID: 29352771
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of cutaneous adverse drug reactions in Southwest China: an 11-year retrospective survey on in-patients of a dermatology ward.
Zhong H; Zhou Z; Wang H; Niu J; Chen W; Song Z; Hao F
Dermatitis; 2012; 23(2):81-5. PubMed ID: 22653124
[TBL] [Abstract][Full Text] [Related]
11. A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India.
Ashifha S; Vijayashree J; Vudayana K; Chintada D; P P; G P; Unnikrishnan P
Cureus; 2023 Apr; 15(4):e37596. PubMed ID: 37197134
[TBL] [Abstract][Full Text] [Related]
12. Medication-related adverse events during hospitalization: a retrospective patient record review study in The Netherlands.
Damen NL; Baines R; Wagner C; Langelaan M
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):32-39. PubMed ID: 27193415
[TBL] [Abstract][Full Text] [Related]
13. Nevirapine: Most Common Cause of Cutaneous Adverse Drug Reactions in an Outpatient Department of a Tertiary Care Hospital.
Pawar MP; Pore SM; Pradhan SN; Burute SR; Bhoi UY; Ramanand SJ
J Clin Diagn Res; 2015 Nov; 9(11):FC17-20. PubMed ID: 26672558
[TBL] [Abstract][Full Text] [Related]
14. A study of use of fixed dose combinations in Ahmedabad, India.
Balat JD; Gandhi AM; Patel PP; Dikshit RK
Indian J Pharmacol; 2014; 46(5):503-9. PubMed ID: 25298579
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an outpatient department (OPD)-based prescribing pattern of fixed-dose combinations in a tertiary care institute in Central India.
Chandel S; Rai N; Balakrishnan S; Jhaj R; Vishwe A; Gour P; Santenna C; Sharma S
J Basic Clin Physiol Pharmacol; 2020 Feb; 31(3):. PubMed ID: 32031977
[TBL] [Abstract][Full Text] [Related]
16. Sex Differences in the Risk of Cutaneous Adverse Drug Reactions Induced by Antiseizure Medications: A Systematic Review and Meta-analysis.
Alfares I; Javaid MS; Chen Z; Anderson A; Antonic-Baker A; Kwan P
CNS Drugs; 2021 Feb; 35(2):161-176. PubMed ID: 33580477
[TBL] [Abstract][Full Text] [Related]
17. CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients.
Boonyagars L; Hirunwiwatkul P; Hurst CP
Int J Tuberc Lung Dis; 2017 Mar; 21(3):338-344. PubMed ID: 28225346
[TBL] [Abstract][Full Text] [Related]
18. Ciprofloxacin-induced cutaneous adverse drug events: a systematic review of descriptive studies.
Kashyap A; Sreenivasan S; Rajan AK; Rashid M; Chhabra M
J Basic Clin Physiol Pharmacol; 2021 Mar; 33(3):327-346. PubMed ID: 33725760
[TBL] [Abstract][Full Text] [Related]
19. Clinical profile of cutaneous adverse drug reactions: a retrospective study of 1883 hospitalized patients from 2007 to 2016 in Shanghai, China.
Yang F; Chen Z; Chen SA; Zhu Q; Wang L; Xiong H; Fu H; Luo X
Eur J Dermatol; 2020 Feb; 30(1):24-31. PubMed ID: 32031529
[TBL] [Abstract][Full Text] [Related]
20. An Epidemiological and Clinical Analysis of Cutaneous Adverse Drug Reactions Seen in a Tertiary Care Outpatient Clinic in Cairo, Egypt.
El-Nabarawy EA; Elmasry MF; El Lawindi MI; Tarek YA
Acta Dermatovenerol Croat; 2018 Oct; 26(3):233-242. PubMed ID: 30390725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
